Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

ProQR Therapeutics Highlights New Platform Data From Presentation On Axiomer RNA Editing Technology, Company Says Platform Demonstrates Robust In Vivo Editing Capabilities Reporting Up To 70% Editing Of ACTB In Liver Of Non-human Primates (NHPS) And Mice

Author: Benzinga Newsdesk | January 19, 2024 08:12am

Posted In: PRQR